Skip to main content
. 2024 Mar 1;15:1338465. doi: 10.3389/fendo.2024.1338465

Table 1.

Profiles of exposure and outcomes in GWAS datasets.

Trait GWAS ID (Data sources) Data Type Case Control Ethnicity Consortium
T2DM PMID: 35551307 Exposure 74,124 824,006 European DIAMANTE
T2DM PMID: 35551307 Exposure 77,418 356,122 East Asian DIAMANTE
NAFLD finngen_R9_NAFLD Outcome 2,275 375,002 European FinnGen biobank
HCC finngen_R9_C3_HEPATOCELLU_CARC_EXALLC Outcome 453 287,137 European FinnGen biobank
Viral Hepatitis finngen_R9_AB1_VIRAL_HEPATITIS Outcome 2,143 375,134 European FinnGen biobank
HBV finngen_R9_K11_CHRONHEP Outcome 885 366,450 European FinnGen biobank
HCV GCST90041714(PMID: 34737426) Outcome 219 456,129 European GWAS catalog
ALT bbj-a-6(PMID: 29403010) Outcome 134,182 East Asian Biobank Japan
AST bbj-a-8(PMID: 29403010) Outcome 134,154 East Asian Biobank Japan
HCC bbj-a-158(PMID: 32514122) Outcome 1,866 195,745 East Asian Biobank Japan
Viral Hepatitis GCST90246018(PMID: 37601966) Outcome 117 75,764 East Asian GWAS catalog
HBV GCST90018584(PMID: 34594039) Outcome 2,234 169,588 East Asian GWAS catalog
HCV GCST90018585(PMID: 34594039) Outcome 7,110 169,588 East Asian GWAS catalog

GWAS, genome-wide association study; ID, identity; T2DM, type 2 diabetes mellitus; DIAMANTE, Diabetes Meta-analysis of Trans-ethnic Association Studies; NAFLD, non-alcoholic fatty liver disease; HCC, hepatocellular carcinoma; HBV, hepatitis B virus; HCV, hepatitis C virus; ALT, Alanine aminotransferase; AST, Aspartate aminotransferase.